Rob Neville (L) and Taneli Jouhikainen
Savara's long-reigning duo both resign in the wake of CF bust
As Savara’s cystic fibrosis development program comes to an end, so will the CEO Rob Neville’s 12-year reign at the company.
Following him out the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
